secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001193125-25-142765
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion shareholders elect all six director nominees at annual meeting
------------------------------------------------------------------------

- All six director nominees elected with >1.3M votes for each; broker non-votes 743,285.
- Ratification of Ernst & Young as auditor approved with 2,072,684 for, 57,547 against.
- Advisory say-on-pay passed with 1,312,697 for, 78,221 against, 6,203 abstain.
- Shareholders selected one-year frequency for future advisory votes on executive compensation.
- Proposal to adjourn meeting if needed also approved with 2,036,703 for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000119312525142765/0001193125-25-142765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000119312525142765/d45045d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer